Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Clioquinol
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/11/2021
STE73-2E9
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/11/2021
RBD immunogen
Potential treatment - pre-clinical evidence Experimental Vaccine Mar/11/2021
Phloretin
Potential treatment - theoretical effect Natural product Antiviral Mar/11/2021
Rosmarinic acid
Potential treatment - theoretical effect Natural product Antiviral Mar/11/2021
Psoralidin
Potential treatment - theoretical effect Natural product Antiviral Mar/11/2021
Daidzin
Potential treatment - theoretical effect Natural product Antiviral Mar/11/2021
Peginterferon alfa-2b
Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/10/2021
Lurasidone
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/10/2021
Elbasvir
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/10/2021
Emetine
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/10/2021
Theaflavin gallate
Potential treatment - theoretical effect Natural product Antiviral Mar/10/2021
Procyanidin B2
Potential treatment - theoretical effect Natural product Antiviral Mar/10/2021
Theaflavin 3,3'-digallate
Potential treatment - theoretical effect Natural product Antiviral Mar/10/2021
ACE2-GpA-RBC
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/10/2021
Pyronaridine
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/10/2021
Tilorone
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/10/2021
Quinacrine
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/10/2021
rMeV-preS
Potential treatment - pre-clinical evidence Experimental Vaccine Mar/09/2021
rMVAs
Potential treatment - pre-clinical evidence Experimental Vaccine Mar/09/2021